CINECA IRIS Institutional Research Information System
IRIS è la piattaforma adottata dall’Università degli Studi di Udine per gestire l’archivio aperto dei prodotti della ricerca. L’archivio contiene articoli, contributi in volume, monografie, interventi pubblicati in atti di convegno, Tesi di dottorato e altri materiali.
EnglishAtypical hyperplasia and lobular carcinoma in situ are rare proliferative breast lesions, growing inside ducts and terminal ducto-lobular units. They represent a marker of increased risk for breast cancer and a non-obligate precursor of malignancy. Evidence available on diagnosis and management is scarce. They are frequently found incidentally associated with other lesions, but can be visible through mammography, ultrasound or magnetic resonance. Due to the risk of underestimation, surgical excision is often performed. The analysis of imaging and histopathological characteristics could help identifying low-risk cases, for which surgery is not necessary. Chemopreventive agents can be used for risk reduction. Careful imaging follow up is mandatory; the role of breast MRI as screening modality is under discussion
Management of atypical lobular hyperplasia, atypical ductal hyperplasia, and lobular carcinoma in situ. / Clauser, Paola; Marino, Maria A.; Baltzer, Pascal A.T.; Bazzocchi, Massimo; Zuiani, Chiara. - In: EXPERT REVIEW OF ANTICANCER THERAPY. - ISSN 1473-7140. - ELETTRONICO. - 16:3(2016), pp. 335-346.
| Titolo: | Management of atypical lobular hyperplasia, atypical ductal hyperplasia, and lobular carcinoma in situ. |
| Autori: | |
| Data di pubblicazione: | 2016 |
| Rivista: | |
| Citazione: | Management of atypical lobular hyperplasia, atypical ductal hyperplasia, and lobular carcinoma in situ. / Clauser, Paola; Marino, Maria A.; Baltzer, Pascal A.T.; Bazzocchi, Massimo; Zuiani, Chiara. - In: EXPERT REVIEW OF ANTICANCER THERAPY. - ISSN 1473-7140. - ELETTRONICO. - 16:3(2016), pp. 335-346. |
| Abstract: | Atypical hyperplasia and lobular carcinoma in situ are rare proliferative breast lesions, growing inside ducts and terminal ducto-lobular units. They represent a marker of increased risk for breast cancer and a non-obligate precursor of malignancy. Evidence available on diagnosis and management is scarce. They are frequently found incidentally associated with other lesions, but can be visible through mammography, ultrasound or magnetic resonance. Due to the risk of underestimation, surgical excision is often performed. The analysis of imaging and histopathological characteristics could help identifying low-risk cases, for which surgery is not necessary. Chemopreventive agents can be used for risk reduction. Careful imaging follow up is mandatory; the role of breast MRI as screening modality is under discussion |
| Handle: | http://hdl.handle.net/11390/1098069 |
| Appare nelle tipologie: | 1.1 Articolo in rivista |
File in questo prodotto:
http://hdl.handle.net/11390/1098069
Copyright © 2020